Logo

American Heart Association

  30
  0


Final ID:

Current and future management of AF in HF

  • Zakeri, Rosita  ( King's College London , London , United Kingdom )
  • Ellinor, Patrick  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Rosita Zakeri: DO have relevant financial relationships ; Consultant:AstraZeneca:Past (completed) ; Other (please indicate in the box next to the company name):SERB Pharmaceuticals, publication fees:Past (completed) ; Speaker:Johnson & Johnson:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) | Patrick Ellinor: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bayer AG:Active (exists now) ; Consultant:Bayer AG:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Sensing the Future of Heart Failure and Arrhythmias

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Invasive monitoring: should we place it in all HF patients?

Mazimba Sula, De Boer Rudolf, Brugts Jan Jasper

Which HF patients are at arrhythmic risk?

Wan Elaine, Solomon Scott

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available